In Pfizer Animal Health efficacy studies, all calves vaccinated with INFORCE 3 survived a severe BRSV challenge in which 95 percent of unvaccinated controls died.1,2 The studies also demonstrated that those calves vaccinated with INFORCE 3 showed fewer lung lesions and reduced viral shedding, indicating vaccinated calves are less likely to suffer from chronic BRSV disease and to transmit disease. Additionally, INFORCE 3 was shown to help prevent respiratory disease caused by IBR and PI3, and reduce IBR and PI3 viral shedding.3,4,5

“It is important to help get dairy and beef calves off to a healthy start and bolster their immune systems early to fight against costly and deadly respiratory diseases,” says Victor Cortese, DVM, PhD, Dipl. ABVP, director, Veterinary Specialties Group, Pfizer Animal Health. “BRSV is a major cause of viral pneumonia in young cattle.6 INFORCE™ 3 has demonstrated unmatched efficacy against BRSV. It is approved for use in cattle of all ages, so it also fits vaccination protocols for incoming stocker and feedlot cattle, and transition dairy cattle.”

In addition to unmatched efficacy and demonstrated safety, INFORCE 3 comes in a new user-friendly package design. Multilingual icons developed specifically for the package allow for quick visual identification of approved uses and handling instructions. The package also offers a tear-off, pressure-sensitive label that includes lot information to assist in inventory control and record-keeping.